CVS Health Beats <br />2nd Quarter Expectations, , Raises Full-Year Forecast.<br />The company announced <br />its second quarter earnings on Aug. 3.<br />CVS Health forecasts its earnings per share for the fiscal year to be between $8.40 and $8.60.<br />This estimate is improved from the company's prior forecast of $8.20 to $8.40.<br />The company reported more the $80.5 billion in revenue, up from its $76 billion expectations.<br />CVS's net income also surpassed expectations, <br />increasing from $2.78 billion to $2.95 billion.<br />Across the board, <br />CVS reported <br />significantly healthier <br />earnings than expected.<br />CEO Karen Lynch touted the company's current model strategy that is service, sales and customer-focused.<br />Our team is delivering <br />meaningful progress on our strategy as we’re striving to become the nation's leading health solutions company, Karen Lynch, CVS CEO, via NBC News.<br />[CVS will] continue to build on this powerful momentum, Karen Lynch, CVS CEO, via NBC News.<br />As consumer behavior shifts with <br />changes in the pandemic.<br />analysts noted that CVS customers <br />made more in-store purchases.<br />The company's loyalty program, CarePass, has seen a 26 percent increase since 2021.<br />While the number of COVID vaccinations administered at CVS has dropped significantly.<br />Lynch reported that the demand for COVID-focused antivirals continues to increase
